Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003325:Coronary Care Units / Q000191:economics; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications*; D012008:Recurrence; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control*
D000889:Anti-Arrhythmia Agents; D008012:Lidocaine